Newsletter

Last Week in Healthcare Reform: 15 August 2022

A new report highlights the value of Medicare Advantage; hospital consolidation continues to reshape the care delivery landscape; elsewhere, nonprofit hospitals’ charity care is found to be lacking; and, Big Pharma’s patent abuse draws increased scrutiny.

Last Week in Healthcare Reform: 8 August 2022

A new report highlights the value of Medicare Advantage; hospital consolidation continues to reshape the care delivery landscape; elsewhere, nonprofit hospitals’ charity care is found to be lacking; and, Big Pharma’s patent abuse draws increased scrutiny.

Last Week in Healthcare Reform: 1 August 2022

A new report highlights the value of Medicare Advantage; hospital consolidation continues to reshape the care delivery landscape; elsewhere, nonprofit hospitals’ charity care is found to be lacking; and, Big Pharma’s patent abuse draws increased scrutiny.

Last Week in Healthcare Reform: 25 July 2022

Critical consumer protections from surprise medical bills face their latest test; a new legislative package seeks to address hospital consolidation; patent abuse keeps the price of inhalers artificially high; and, Medicare-eligible beneficiaries continue to choose Medicare Advantage plans.

Last Week in Healthcare Reform: 18 July 2022

Critical consumer protections from surprise medical bills face their latest test; a new legislative package seeks to address hospital consolidation; patent abuse keeps the price of inhalers artificially high; and, Medicare-eligible beneficiaries continue to choose Medicare Advantage plans.

Last Week in Healthcare Reform: 11 July 2022

Critical consumer protections from surprise medical bills face their latest test; a new legislative package seeks to address hospital consolidation; patent abuse keeps the price of inhalers artificially high; and, Medicare-eligible beneficiaries continue to choose Medicare Advantage plans.

Last Week in Healthcare Reform: June 27th, 2022

Critical consumer protections from surprise medical bills face their latest test; a new legislative package seeks to address hospital consolidation; patent abuse keeps the price of inhalers artificially high; and, Medicare-eligible beneficiaries continue to choose Medicare Advantage plans.

Last Week in Healthcare Reform: June 20th, 2022

How some private equity interests are negatively impacting rural communities; drugmakers invest heavily…in their shareholders; analysis shows broad coverage of insulin products in Medicare Part D; and, clinical waste drives excess healthcare spending.

Last Week in Healthcare Reform: June 13th, 2022

The majority of hospitals fail to comply with price transparency rules; new prescription drugs come with increasingly higher price tags; the No Surprises Act has already prevented millions of surprise medical bills; and, private equity interests continue to exact a heavy toll on our healthcare system.